FDA Approves Daraxonrasib Breakthrough Pancreatic Cancer Drug
FDA Approves Daraxonrasib: A Landmark Moment in Pancreatic Cancer Treatment On August 26, 2026, the U.S. Food and Drug Administration
Read more
Cancer
FDA Approves First RAS-Targeted Drug for Pancreatic Cancer
FDA Approves First RAS-Targeted Drug for Pancreatic Cancer On August 26, 2026, the U.S. Food and Drug Administration granted approval
Read more
First Gulf South Patient Functionally Cured of Sickle Cell With Gene Therapy
Daniel Cressy, 23, became the first person in the Gulf South functionally cured of sickle cell disease using Casgevy gene therapy, while a new study finds younger generations are aging faster biologically, potentially explaining rising early-onset cancer rates. Combined with a 31-state foodborne outbreak and the worsening Bundibugyo virus crisis, here’s this week’s health roundup.
Read more